TrialTranslational stroke research2017

Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients.

Jun Ni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.